About

Abigail Pepin is a radiation oncologist whose research focuses on refining stereotactic body radiation therapy (SBRT) for prostate cancer, with a particular emphasis on improving treatment precision and understanding patient quality of life. Her work has centered on developing less invasive alternatives to traditional brachytherapy, as demonstrated in her highly cited 2017 study on combining intensity-modulated radiation therapy with an SBRT boost for unfavorable prostate cancer (21 citations). Pepin has pioneered the use of iodinated rectal spacers like SpaceOAR Vue™ to protect healthy tissue during robotic SBRT, a technique particularly valuable for patients with MRI contraindications. Her research also explores the hormonal consequences of treatment, notably examining testosterone recovery kinetics and the burden of hot flashes following androgen deprivation therapy. With recent publications tracking five-year outcomes and management of local failures after SBRT, Pepin’s work bridges technical innovation with patient-centered care, helping to establish SBRT as a viable, less invasive option while addressing the real-world side effects that matter most to patients.

Research Focus

Key Achievements

5
H-Index
6
Papers
50
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year Toxicity
21 citations · 2017
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 45
🏛 Institutions: George Washington University, Georgetown University, Beth Israel Deaconess Medical Center, University of Pennsylvania

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago